Relationship of HHV-6B Virus to Seizures and Brain Injury
NCT00597285 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2019-12-16
Summary
This study will look for evidence that a virus called HHV-6B may be related to seizures and to a form of brain injury called mesial temporal sclerosis that is associated with seizures. The study will use new, more sensitive brain scans to try to detect brain regions that might be affected by the virus and will examine cerebrospinal fluid (CSF, the fluid that bathes the brain and spinal cord) for evidence of the virus as well.
Healthy volunteers and people with seizures uncontrolled by anti-epileptic drugs who are between 18 and 45 years of age may be eligible for this study. Candidates are screened with a physical examination and laboratory tests.
Participants undergo the following procedures:
* PET scan. This test uses a radioactive chemical called 18FDG, which is detected by the PET scanner to obtain images of the brain. The subject lies on a table with his or her head positioned in the scanner. A swimming cap with a small light reflector is placed on the head to monitor the position of the head during the scan. A catheter (plastic tube) is inserted into an artery at the wrist or elbow crease of the arm for obtaining blood samples during the scan, and a second catheter is placed in a vein in the other arm for injecting the 18FDG. The scan takes up to 2 hours. A second scan may be done over an additional 15 minutes.
* MRI. This test uses a strong magnetic field and radio waves to obtain images of the brain. The subject lies on a table that can slide in and out of a metal cylinder surrounded by a magnetic field. Most scans last between 45 and 90 minutes.
* Lumbar puncture. The subject sits upright or lies on a table with the knees curled to the chest for this procedure. A local anesthetic is injected to numb the skin and a needle is inserted in the space between the bones in the lower back where the CSF circulates below the spinal cord. A small amount of fluid is collected through the needle.
* Blood tests. About 4 tablespoons of blood are drawn for viral tests.
Conditions
- Epilepsy
- HHV6B Infection
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
William H Theodore, M.D. · National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-01-03
- Completion
- 2013-11-01
Countries
- United States
Study Locations
More Related Trials
-
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
NCT01521130 ·Status: COMPLETED ·Phase: PHASE1
-
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
NCT00454935 ·Status: UNKNOWN
-
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
NCT06081283 ·Status: TERMINATED ·Phase: PHASE4
-
Cognitive Effects of Treatment of Interictal Discharges
NCT00916149 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Modulation of Brain Oscillations in Memory Processing
NCT05594017 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Prevention of Epileptic Seizures in Acute intraCerebral Haemorrhage
NCT02631759 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam to Prevent Post-Traumatic Epilepsy
NCT01463033 ·Status: COMPLETED ·Phase: PHASE2
-
Cholinergic Enhancement of Theta
NCT07228338 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism
NCT00001489 ·Status: COMPLETED
-
Neurodevelopmental Impact of Epilepsy on Autonomic Function in Dravet Syndrome
NCT05472389 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
NCT06866691 ·Status: RECRUITING ·Phase: PHASE4
-
Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?
NCT03054285 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization
NCT03250377 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
NCT00629889 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
NCT07336992 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam
NCT00761774 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam for Benign Rolandic Epilepsy
NCT00181116 ·Status: COMPLETED ·Phase: PHASE4
-
Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304
NCT01457989 ·Status: COMPLETED
-
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
NCT00464269 ·Status: COMPLETED ·Phase: PHASE3
-
Seizure Activity in Alzheimer's Disease
NCT01554683 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use Program With Brivaracetam for the Treatment of Patients With Epilepsy
NCT03532516 ·Status: AVAILABLE
-
Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery
NCT00571155 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Brivaracetam in Subjects With Partial Onset Seizures
NCT00175929 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
NCT00175825 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)
NCT01278173 ·Status: COMPLETED ·Phase: PHASE4